180 related articles for article (PubMed ID: 28861631)
1. Unenhanced magnetic resonance imaging immediately after radiofrequency ablation of liver malignancy: preliminary results.
D'Onofrio M; Cardobi N; Ruzzenente A; Conci S; Ciaravino V; Guglielmi A; Mucelli RP
Abdom Radiol (NY); 2018 Jun; 43(6):1379-1385. PubMed ID: 28861631
[TBL] [Abstract][Full Text] [Related]
2. Radiofrequency ablation of hepatocellular carcinoma: predicting success using contrast-enhanced sonography.
Dill-Macky MJ; Asch M; Burns P; Wilson S
AJR Am J Roentgenol; 2006 May; 186(5 Suppl):S287-95. PubMed ID: 16632690
[TBL] [Abstract][Full Text] [Related]
3. Contrast-enhanced ultrasound improves real-time imaging of ablation region during radiofrequency ablation: preliminary results.
Wiggermann P; Zuber-Jerger I; Zausig Y; Loss M; Scherer MN; Schreyer AG; Stroszczynski C; Jung EM
Clin Hemorheol Microcirc; 2011; 49(1-4):43-54. PubMed ID: 22214677
[TBL] [Abstract][Full Text] [Related]
4. Irreversible electroporation of hepatocellular carcinoma: preliminary report on the diagnostic accuracy of magnetic resonance, computer tomography, and contrast-enhanced ultrasound in evaluation of the ablated area.
Granata V; de Lutio di Castelguidone E; Fusco R; Catalano O; Piccirillo M; Palaia R; Izzo F; Gallipoli AD; Petrillo A
Radiol Med; 2016 Feb; 121(2):122-31. PubMed ID: 26345332
[TBL] [Abstract][Full Text] [Related]
5. Ablative safety margin depicted by fusion imaging with post-treatment contrast-enhanced ultrasound and pre-treatment CECT/CEMRI after radiofrequency ablation for liver cancers.
Bo XW; Xu HX; Guo LH; Sun LP; Li XL; Zhao CK; He YP; Liu BJ; Li DD; Zhang K; Wang D
Br J Radiol; 2017 Oct; 90(1078):20170063. PubMed ID: 28749166
[TBL] [Abstract][Full Text] [Related]
6. Fusion imaging of contrast-enhanced ultrasound and contrast-enhanced CT or MRI before radiofrequency ablation for liver cancers.
Bo XW; Xu HX; Wang D; Guo LH; Sun LP; Li XL; Zhao CK; He YP; Liu BJ; Li DD; Zhang K
Br J Radiol; 2016 Nov; 89(1067):20160379. PubMed ID: 27626506
[TBL] [Abstract][Full Text] [Related]
7. Fusion imaging with contrast-enhanced ultrasonography for evaluating the early therapeutic efficacy of radiofrequency ablation for small hypervascular hepatocellular carcinomas with iso-echoic or unclear margins on conventional ultrasonography.
Nishigori S; Numata K; Irie K; Fukuda H; Chuma M; Maeda S
J Med Ultrason (2001); 2018 Jul; 45(3):405-415. PubMed ID: 29362966
[TBL] [Abstract][Full Text] [Related]
8. Percutaneous Radiofrequency Ablation of Small (1-2 cm) Hepatocellular Carcinomas Inconspicuous on B-Mode Ultrasonographic Imaging: Usefulness of Combined Fusion Imaging with MRI and Contrast-Enhanced Ultrasonography.
Lee MW; Lim HK; Rhim H; Cha DI; Kang TW; Song KD; Min JH; Gwak GY; Kim S; Lu DSK
Can J Gastroenterol Hepatol; 2018; 2018():7926923. PubMed ID: 30013957
[TBL] [Abstract][Full Text] [Related]
9. Imaging evaluation of ablative margin and index tumor immediately after radiofrequency ablation for hepatocellular carcinoma: comparison between multidetector-row CT and MR imaging.
Kim SM; Shin SS; Lee BC; Kim JW; Heo SH; Lim HS; Jeong YY
Abdom Radiol (NY); 2017 Oct; 42(10):2527-2537. PubMed ID: 28409202
[TBL] [Abstract][Full Text] [Related]
10. Prediction of Local Tumor Progression after Radiofrequency Ablation (RFA) of Hepatocellular Carcinoma by Assessment of Ablative Margin Using Pre-RFA MRI and Post-RFA CT Registration.
Yoon JH; Lee JM; Klotz E; Woo H; Yu MH; Joo I; Lee ES; Han JK
Korean J Radiol; 2018; 19(6):1053-1065. PubMed ID: 30386137
[TBL] [Abstract][Full Text] [Related]
11. Percutaneous US/MRI Fusion-guided Radiofrequency Ablation for Recurrent Subcentimeter Hepatocellular Carcinoma: Technical Feasibility and Therapeutic Outcomes.
Song KD; Lee MW; Rhim H; Kang TW; Cha DI; Sinn DH; Lim HK
Radiology; 2018 Sep; 288(3):878-886. PubMed ID: 29916771
[TBL] [Abstract][Full Text] [Related]
12. [Imaging evaluation of efficacy of radiofrequency ablation treatment for hepatic cancer].
Zhang ZJ; Wu MC; Liu Q; Chen D
Zhonghua Zhong Liu Za Zhi; 2005 Oct; 27(10):616-9. PubMed ID: 16438873
[TBL] [Abstract][Full Text] [Related]
13. The Role of Contrast-enhanced Ultrasound in Guiding Radiofrequency Ablation of Hepatocellular Carcinoma: A Retrospective Study.
Chan AK; Hegarty C; Klass D; Yoshida E; Chung S; Liu DM; Ho SG; Harris AC
Can Assoc Radiol J; 2015 May; 66(2):171-8. PubMed ID: 25637354
[TBL] [Abstract][Full Text] [Related]
14. Percutaneous radiofrequency ablation of hepatocellular carcinoma: fusion imaging guidance for management of lesions with poor conspicuity at conventional sonography.
Lee MW; Rhim H; Cha DI; Kim YJ; Choi D; Kim YS; Lim HK
AJR Am J Roentgenol; 2012 Jun; 198(6):1438-44. PubMed ID: 22623560
[TBL] [Abstract][Full Text] [Related]
15. Safety margin of radiofrequency ablation for hepatocellular carcinoma: a prospective study using magnetic resonance imaging with superparamagnetic iron oxide.
Fukuda K; Mori K; Hasegawa N; Nasu K; Ishige K; Okamoto Y; Shiigai M; Abei M; Minami M; Hyodo I
Jpn J Radiol; 2019 Jul; 37(7):555-563. PubMed ID: 31102138
[TBL] [Abstract][Full Text] [Related]
16. Assessment of ablative margin by unenhanced magnetic resonance imaging after radiofrequency ablation for hepatocellular carcinoma.
Koda M; Tokunaga S; Miyoshi K; Kishina M; Fujise Y; Kato J; Matono T; Okamoto K; Murawaki Y; Kakite S
Eur J Radiol; 2012 Oct; 81(10):2730-6. PubMed ID: 22137612
[TBL] [Abstract][Full Text] [Related]
17. Contrast-enhanced US-guided radiofrequency ablation of hepatocellular carcinoma.
Rajesh S; Mukund A; Arora A; Jain D; Sarin SK
J Vasc Interv Radiol; 2013 Aug; 24(8):1235-40. PubMed ID: 23796857
[TBL] [Abstract][Full Text] [Related]
18. Integrating contrast-enhanced sonography in the follow-up algorithm of hepatocellular carcinoma treated with radiofrequency ablation: single cancer center experience.
Catalano O; Izzo F; Vallone P; Sandomenico F; Albino V; Nunziata A; Fusco R; Petrillo A
Acta Radiol; 2015 Feb; 56(2):133-42. PubMed ID: 24523360
[TBL] [Abstract][Full Text] [Related]
19. Assessment of radiofrequency ablation margin by MRI-MRI image fusion in hepatocellular carcinoma.
Wang XL; Li K; Su ZZ; Huang ZP; Wang P; Zheng RQ
World J Gastroenterol; 2015 May; 21(17):5345-51. PubMed ID: 25954109
[TBL] [Abstract][Full Text] [Related]
20. [Clinical application of ultrasound-guided radiofrequency ablation for primary hepatocellular carcinoma near the liver surface].
Wu J; Lin S; Wu W; Yan K; Dai Q; Chen M
Zhonghua Zhong Liu Za Zhi; 2015 Dec; 37(12):933-7. PubMed ID: 26887624
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]